Present review article highlights various cardiovascular risk prediction biomarkers by
incorporating both traditional risk factors to be used as diagnostic markers and recent …

Importance: Despite the availability of a vaccine against the severe acute respiratory
syndrome-coronavirus-2 (SARS-CoV-2), humans will have to live with this virus and the after …

Abstract Lipoprotein (a)[Lp (a)] is a highly heritable cardiovascular risk factor. Although
discovered more than 50 years ago, Lp (a) has recently re-emerged as a major focus in the …

At present, lipoprotein apheresis, combined with high-dose statin and ezetimibe therapy, is
the best available means of treating patients with homozygous and statin-refractory …

During pregnancy physiological changes occur in the lipid metabolism due to changing
hormonal conditions: the LDL cholesterol (LDL-C), triglycerides (TG) and lipoprotein (a)[Lp …

Familial hypercholesterolemia (FH) is a common genetic disorder that causes elevated LDL
cholesterol levels from birth. Untreated FH accelerates atherosclerosis and predisposes …

Background Homozygous familial hypercholesterolemia (hoFH) is a rare inherited disorder
characterized by extreme elevation of low-density lipoprotein (LDL) cholesterol, accelerated …

Familial hypercholesterolaemia, familial combined hyperlipidaemia (FCH) and elevated
lipoprotein (a) are common, inherited disorders of apolipoprotein B metabolism that …

Introduction To summarize the clinical experiences with double plasma purification (DPP).
Method Using Plasauto iQ automatic blood purification system, model KM‐9000 for DPP …

The theoretical prevalence of heFH has been generally accepted to be 1: 50022) and higher
in some populations because of a founder effect23). Recent studies from Denmark4) …